Pharmaceutical Technology20 小时
Dazostinag sodium by Takeda Pharmaceutical for Paranasal Sinus And Nasal Cavity Cancer ...
Dazostinag sodium is under clinical development by Takeda Pharmaceutical and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer.
Pharmaceutical Technology21 小时
Cabometyx by Exelixis for Salivary Gland Cancer: Likelihood of Approval
Cabometyx is under clinical development by Exelixis and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase transition ...